Most Recent

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

image: Captivated by Chromosomes

Captivated by Chromosomes

By | December 1, 2017

Peering through a microscope since age 14, Joseph Gall, now 89, still sees wonder at the other end.

0 Comments

A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.

0 Comments

image: In Situ Hybridization Explained

In Situ Hybridization Explained

By | December 1, 2017

Profilee Joseph Gall of the Carnegie Institute describes the process, which he developed in the 1960s.

0 Comments

The Lawrence Berkeley National Laboratory researcher’s work will help predict how the Arctic is responding to climate change—and the global effects of those changes.

0 Comments

image: Researchers Make Knockout Stem Cell Lines in One Step

Researchers Make Knockout Stem Cell Lines in One Step

By | December 1, 2017

Combining gene editing and stem-cell induction improves efficiency of functional genetic analyses.

0 Comments

image: Infographic: Combo Method of Stem Cell Generation

Infographic: Combo Method of Stem Cell Generation

By | December 1, 2017

Simultaneous exposure to reprogramming and gene-editing plasmids efficiently produces edited pluripotent colonies.

0 Comments

New technologies reveal the dynamic changes in mouse and human embryos during the first week after fertilization.

1 Comment

Activating genes for reprogramming factors for a short time transforms large numbers of differentiated cells into multipotent forms that could be useful for cell-based therapies.

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

Popular Now

  1. Secret Eugenics Conference Uncovered at University College London
  2. Like Humans, Walruses and Bats Cuddle Infants on Their Left Sides
  3. How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
  4. Scientists Continue to Use Outdated Methods
AAAS